The Public Financing of Pharmaceuticals

The Public Financing of Pharmaceuticals

An Economic Approach

Edited by Jaume Puig-Junoy

This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability.

Chapter 11: Review of economic studies of the pharmaceutical industry published over the last 20 years by Spanish economists

F. Lobo, M. Cabañas Sáenz and R. González Pérez

Subjects: economics and finance, health policy and economics, industrial economics, public finance


F. Lobo, M. Cabañas Sáenz and R. González Pérez SCOPE AND WORK PLAN* This review encompasses works published between 1 January 1980 and 31 December 1999. To avoid it extending interminably, we give priority to economic studies by economists, although we apply this restriction flexibly, especially in the bibliographical appendix.** In principle, the works we deal with must have been published in a scientific journal of some sort. This condition is treated fairly broadly. We include Spanish journals that did not use (and in some cases still do not use) anonymous referees, as long as their level of quality is admitted in the profession. Naturally, we also consider articles published in foreign scientific journals with anonymous referees. We also mention books and book chapters in this field. We pay close attention to doctoral theses, owing to their importance for * The Health Economics Association (AES) asked F. Lobo to prepare this review, one of several that marked the occasion of its 20th annual conference, held in Palma de Mallorca. With help from Laura Pellisé, he presented a preliminary version of this review at the conference. The chairman of the Scientific Committee gave him six criteria: identification of the works, accessibility, theoretical development, statistical data and techniques, recommendations for measures and action, valuation of the importance of the study and repercussion on health policy. These reviews were published in F. Antoñanzas, J. Fuster and E. Castaño (eds) (2000), Libro de ponencias de las XX Jornadas de...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information